Scientists have developed a tiny, injectable device that can control nerve activity without surgery, batteries, or wires, potentially transforming treatment for chronic pain and movement disorders.

Over the last century, pharmacology has revolutionized the practice of medicine. Our next revolution in medicine may come with bioelectronic treatments that reduce inflammation.

Brain-computer interfaces, neuromodulators, and bioelectronic medical devices are reaching their limits with standard chips.

Spark Biomedical, a commercial-stage bioelectronic medicine company pioneering non-invasive multi-path neurostimulation devices, announced ...

Company remains focused on its transition toward commercial revenue generation and the advancement of its U.S. clinical programs ...

Funding from European and US investors will accelerate product launch, partner adoption and international expansion.

A soft bioelectronic system with a thermally responsive hydrogel interface gives neurosurgeons real-time, quantitative ...

The Imperial College London spinout is moving from technology validation to commercial scale-up, with its semiconductor ...

MintNeuro, a semiconductor company building specialised chips for neural devices from implants to wearables, today announces a $5 ...

The bioelectronic medicine market is expected to witness significant growth over the coming years, driven by increasing adoption of neuromodulation and electrical stimulation technologies for the ...

Cala®, the bioelectronic medicine leader, today announced nationwide availability of the Cala kIQ® Plus System, the latest ...

Crystal structures of an engineered hyperthermophilic sugar dehydrogenase reveal how two mutations relieve a steric barrier ...